Treatment of ophthalmic segment carotid aneurysms using the pipeline embolization device: Clinical and angiographic follow-up

Karam Moon, Felipe C. Albuquerque, Andrew F. Ducruet, R. Webster Crowley, Cameron McDougall

Research output: Contribution to journalArticle

Abstract

Objectives: Aneurysms of the ophthalmic segment of the internal carotid artery (ICA) often present unique challenges to endovascular treatment due to their proximity to or involvement of the ophthalmic artery, and the subsequent risk of post-operative visual complications. The pipeline embolization device (PED) represents a paradigm shift and promising new therapy in the treatment of intracranial aneurysms. We reviewed the ophthalmic segment ICA aneurysms treated with the PED at Barrow Neurological Institute (BNI) to report outcome data, including patency of the ophthalmic artery and visual complications. Methods: The prospectively maintained BNI endovascular database was reviewed for all patients with ophthalmic segment ICA aneurysms treated with the PED since May 2011. Patient charts and digital subtraction angiograms were reviewed to report angiographic outcomes and visual complications. Only patients with at least 6 months of follow-up were included in the analysis. Results: Of 30 patients treated with ophthalmic segment aneurysms during the study period, sufficient follow-up was available for 29 patients with 38 aneurysms, all of which were treated electively. The PED was successfully deployed for all lesions, with 92.1% complete or near-complete obliteration rate at angiographic follow-up. All but one patient were found to have a patent ophthalmic artery at short-term follow-up and 100% of patients retained intact vision. Five patients had minor periprocedural hemorrhagic complications but no permanent morbidities. There were no intracranial hemorrhages, thromboembolic phenomena, vessel dissections, or mortalities. Conclusion: Treatment of ophthalmic segment ICA aneurysms with the PED is safe and effective at shortterm follow-up.

Original languageEnglish (US)
Pages (from-to)344-350
Number of pages7
JournalNeurological Research
Volume36
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Aneurysm
Equipment and Supplies
Internal Carotid Artery
Ophthalmic Artery
Therapeutics
Intracranial Hemorrhages
Intracranial Aneurysm
Dissection
Angiography
Databases
Morbidity
Mortality

Keywords

  • Coil embolization
  • Endovascular
  • Ophthalmic segment aneurysm
  • Pipeline embolization device

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Treatment of ophthalmic segment carotid aneurysms using the pipeline embolization device : Clinical and angiographic follow-up. / Moon, Karam; Albuquerque, Felipe C.; Ducruet, Andrew F.; Webster Crowley, R.; McDougall, Cameron.

In: Neurological Research, Vol. 36, No. 4, 01.01.2014, p. 344-350.

Research output: Contribution to journalArticle

Moon, Karam ; Albuquerque, Felipe C. ; Ducruet, Andrew F. ; Webster Crowley, R. ; McDougall, Cameron. / Treatment of ophthalmic segment carotid aneurysms using the pipeline embolization device : Clinical and angiographic follow-up. In: Neurological Research. 2014 ; Vol. 36, No. 4. pp. 344-350.
@article{ab849164a03f48a99ef1e6911d5e764e,
title = "Treatment of ophthalmic segment carotid aneurysms using the pipeline embolization device: Clinical and angiographic follow-up",
abstract = "Objectives: Aneurysms of the ophthalmic segment of the internal carotid artery (ICA) often present unique challenges to endovascular treatment due to their proximity to or involvement of the ophthalmic artery, and the subsequent risk of post-operative visual complications. The pipeline embolization device (PED) represents a paradigm shift and promising new therapy in the treatment of intracranial aneurysms. We reviewed the ophthalmic segment ICA aneurysms treated with the PED at Barrow Neurological Institute (BNI) to report outcome data, including patency of the ophthalmic artery and visual complications. Methods: The prospectively maintained BNI endovascular database was reviewed for all patients with ophthalmic segment ICA aneurysms treated with the PED since May 2011. Patient charts and digital subtraction angiograms were reviewed to report angiographic outcomes and visual complications. Only patients with at least 6 months of follow-up were included in the analysis. Results: Of 30 patients treated with ophthalmic segment aneurysms during the study period, sufficient follow-up was available for 29 patients with 38 aneurysms, all of which were treated electively. The PED was successfully deployed for all lesions, with 92.1{\%} complete or near-complete obliteration rate at angiographic follow-up. All but one patient were found to have a patent ophthalmic artery at short-term follow-up and 100{\%} of patients retained intact vision. Five patients had minor periprocedural hemorrhagic complications but no permanent morbidities. There were no intracranial hemorrhages, thromboembolic phenomena, vessel dissections, or mortalities. Conclusion: Treatment of ophthalmic segment ICA aneurysms with the PED is safe and effective at shortterm follow-up.",
keywords = "Coil embolization, Endovascular, Ophthalmic segment aneurysm, Pipeline embolization device",
author = "Karam Moon and Albuquerque, {Felipe C.} and Ducruet, {Andrew F.} and {Webster Crowley}, R. and Cameron McDougall",
year = "2014",
month = "1",
day = "1",
doi = "10.1179/1743132814Y.0000000322",
language = "English (US)",
volume = "36",
pages = "344--350",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - Treatment of ophthalmic segment carotid aneurysms using the pipeline embolization device

T2 - Clinical and angiographic follow-up

AU - Moon, Karam

AU - Albuquerque, Felipe C.

AU - Ducruet, Andrew F.

AU - Webster Crowley, R.

AU - McDougall, Cameron

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives: Aneurysms of the ophthalmic segment of the internal carotid artery (ICA) often present unique challenges to endovascular treatment due to their proximity to or involvement of the ophthalmic artery, and the subsequent risk of post-operative visual complications. The pipeline embolization device (PED) represents a paradigm shift and promising new therapy in the treatment of intracranial aneurysms. We reviewed the ophthalmic segment ICA aneurysms treated with the PED at Barrow Neurological Institute (BNI) to report outcome data, including patency of the ophthalmic artery and visual complications. Methods: The prospectively maintained BNI endovascular database was reviewed for all patients with ophthalmic segment ICA aneurysms treated with the PED since May 2011. Patient charts and digital subtraction angiograms were reviewed to report angiographic outcomes and visual complications. Only patients with at least 6 months of follow-up were included in the analysis. Results: Of 30 patients treated with ophthalmic segment aneurysms during the study period, sufficient follow-up was available for 29 patients with 38 aneurysms, all of which were treated electively. The PED was successfully deployed for all lesions, with 92.1% complete or near-complete obliteration rate at angiographic follow-up. All but one patient were found to have a patent ophthalmic artery at short-term follow-up and 100% of patients retained intact vision. Five patients had minor periprocedural hemorrhagic complications but no permanent morbidities. There were no intracranial hemorrhages, thromboembolic phenomena, vessel dissections, or mortalities. Conclusion: Treatment of ophthalmic segment ICA aneurysms with the PED is safe and effective at shortterm follow-up.

AB - Objectives: Aneurysms of the ophthalmic segment of the internal carotid artery (ICA) often present unique challenges to endovascular treatment due to their proximity to or involvement of the ophthalmic artery, and the subsequent risk of post-operative visual complications. The pipeline embolization device (PED) represents a paradigm shift and promising new therapy in the treatment of intracranial aneurysms. We reviewed the ophthalmic segment ICA aneurysms treated with the PED at Barrow Neurological Institute (BNI) to report outcome data, including patency of the ophthalmic artery and visual complications. Methods: The prospectively maintained BNI endovascular database was reviewed for all patients with ophthalmic segment ICA aneurysms treated with the PED since May 2011. Patient charts and digital subtraction angiograms were reviewed to report angiographic outcomes and visual complications. Only patients with at least 6 months of follow-up were included in the analysis. Results: Of 30 patients treated with ophthalmic segment aneurysms during the study period, sufficient follow-up was available for 29 patients with 38 aneurysms, all of which were treated electively. The PED was successfully deployed for all lesions, with 92.1% complete or near-complete obliteration rate at angiographic follow-up. All but one patient were found to have a patent ophthalmic artery at short-term follow-up and 100% of patients retained intact vision. Five patients had minor periprocedural hemorrhagic complications but no permanent morbidities. There were no intracranial hemorrhages, thromboembolic phenomena, vessel dissections, or mortalities. Conclusion: Treatment of ophthalmic segment ICA aneurysms with the PED is safe and effective at shortterm follow-up.

KW - Coil embolization

KW - Endovascular

KW - Ophthalmic segment aneurysm

KW - Pipeline embolization device

UR - http://www.scopus.com/inward/record.url?scp=84896283507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896283507&partnerID=8YFLogxK

U2 - 10.1179/1743132814Y.0000000322

DO - 10.1179/1743132814Y.0000000322

M3 - Article

C2 - 24617935

AN - SCOPUS:84896283507

VL - 36

SP - 344

EP - 350

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 4

ER -